A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways

Journal: Nature Communications

Published: 2020-06-12

DOI: 10.1038/s41467-020-16786-5

Affiliations: 11

Authors: 16

Go to article
Institutions Share
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.52
UW Medicine, United States of America (USA) 0.13
Spanish National Cancer Research Centre (CNIO), Spain 0.13
National Cancer Center (NCC), Japan 0.06
University of Washington (UW), United States of America (USA) 0.06
Clinical Research Division, FHCRC, United States of America (USA) 0.06
Benaroya Research Institute at Virginia Mason (BRI), United States of America (USA) 0.03
Seattle Translational Tumor Research (STTR), United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER